15-Bio ApS: Financial statements 2024
CVR: 39889277
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
15-Bio ApS (CVR 39889277) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -8,126 and a net result of DKK -8,126 compared with DKK -5,001 the year before. Equity in the 2024 report amounted to DKK 18,422. The solvency ratio was 41%.
- Gross Profit
- DKK -8,126
- Profit/Loss
- DKK -8,126
- Equity
- DKK 18,422
- Total Assets
- DKK 44,880
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -8 t. | -8 t. | 18 t. | - |
| 2023 | - | -5 t. | -5 t. | 27 t. | - |
| 2022 | - | -5 t. | -4 t. | 32 t. | - |
| 2021 | - | -6 t. | -7 t. | 35 t. | - |
| 2020 | - | -1 t. | -1 t. | 42 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
15-Bio ApS has published its annual report for 2023. Gross profit came to DKK -5,001, and the net result was DKK -5,001.
About 15-Bio ApS
15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity in the 2025 report amounted to DKK 11,547.